HemaSphere (Jun 2022)
P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA
- A. Bazinet,
- E. Jabbour,
- H. Kantarjian,
- K. Chien,
- C. DiNardo,
- M. Ohanian,
- N. Daver,
- R. Kanagal-Shamanna,
- T. Kadia,
- K. Takahashi,
- L. Masarova,
- N. Short,
- Y. Alvarado,
- P. Thompson,
- G. Montalban-Bravo,
- M. Yilmaz,
- F. Ravandi,
- M. Konopleva,
- M. Andreeff,
- S. Kornblau,
- N. Pemmaraju,
- D. Hammond,
- H. Schneider,
- B. Mirabella,
- G. Garcia-Manero
Affiliations
- A. Bazinet
- 1 Leukemia
- E. Jabbour
- 1 Leukemia
- H. Kantarjian
- 1 Leukemia
- K. Chien
- 1 Leukemia
- C. DiNardo
- 1 Leukemia
- M. Ohanian
- 1 Leukemia
- N. Daver
- 1 Leukemia
- R. Kanagal-Shamanna
- 2 Hematopathology, University of Texas MD Anderson Cancer Center, Houston, United States of America
- T. Kadia
- 1 Leukemia
- K. Takahashi
- 1 Leukemia
- L. Masarova
- 1 Leukemia
- N. Short
- 1 Leukemia
- Y. Alvarado
- 1 Leukemia
- P. Thompson
- 1 Leukemia
- G. Montalban-Bravo
- 1 Leukemia
- M. Yilmaz
- 1 Leukemia
- F. Ravandi
- 1 Leukemia
- M. Konopleva
- 1 Leukemia
- M. Andreeff
- 1 Leukemia
- S. Kornblau
- 1 Leukemia
- N. Pemmaraju
- 1 Leukemia
- D. Hammond
- 1 Leukemia
- H. Schneider
- 1 Leukemia
- B. Mirabella
- 1 Leukemia
- G. Garcia-Manero
- 1 Leukemia
- DOI
- https://doi.org/10.1097/01.HS9.0000845912.50259.67
- Journal volume & issue
-
Vol. 6
pp. 652 – 653
Abstract
No abstracts available.